{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T08:02:03Z","timestamp":1795075323903,"version":"4.10.2"},"reference-count":253,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015373","name":"Key Laboratory of Nuclear Medicine and Molecular Imaging of Sichuan Province","doi-asserted-by":"publisher","award":["HYX19014"],"award-info":[{"award-number":["HYX19014"]}],"id":[{"id":"10.13039\/501100015373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopha.2022.113903","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T20:19:30Z","timestamp":1666383570000},"page":"113903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"special_numbering":"C","title":["Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy"],"prefix":"10.1016","volume":"156","author":[{"given":"Ye","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saixian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113903_bib1","first-page":"45","article-title":"Advances in the techniques and methodologies of cancer gene therapy","volume":"27","author":"Sun","year":"2019","journal-title":"Discov. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib2","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.biopha.2022.113903_bib3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ymthe.2020.12.035","article-title":"Telomerase therapy attenuates cardiotoxic effects of doxorubicin","volume":"29","author":"Chatterjee","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib5","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1038\/s41598-020-64828-1","article-title":"Co-delivery of doxorubicin and curcumin with polypeptide nanocarrier for synergistic lymphoma therapy","volume":"10","author":"Guo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib6","first-page":"137","article-title":"A motif-based network analysis of regulatory patterns in doxorubicin effects on treating breast cancer, a systems biology study","volume":"14","author":"Dehghan","year":"2022","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.biopha.2022.113903_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2174\/0929867323666161214120355","article-title":"Topoisomerases and anthracyclines: recent advances and perspectives in anticancer therapy and prevention of cardiotoxicity","volume":"24","author":"Mordente","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113903_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/1440-1681.13036","article-title":"Update on pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity","volume":"46","author":"Corremans","year":"2019","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.biopha.2022.113903_bib9","doi-asserted-by":"crossref","first-page":"8841726","DOI":"10.1155\/2021\/8841726","article-title":"Antioxidant and anti-inflammatory effects of crocin ameliorate doxorubicin-induced nephrotoxicity in rats","volume":"2021","author":"Hussain","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/19390211.2017.1335822","article-title":"Ameliorative effect of gallic acid in doxorubicin-induced hepatotoxicity in wistar rats through antioxidant defense system","volume":"Suppl, 15","author":"Omobowale","year":"2018","journal-title":"J. Diet."},{"key":"10.1016\/j.biopha.2022.113903_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.omtn.2022.03.007","article-title":"The circular RNA circNlgnmediates doxorubicin-inducedcardiac remodeling and fibrosis","volume":"28","author":"Xu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2022.113903_bib12","article-title":"Doxorubicin-induced cognitive impairment: the mechanistic insights","volume":"11","author":"Du J","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113903_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.113903_bib14","article-title":"Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study","volume":"6","author":"Baker","year":"2020","journal-title":"J. Cancer Metastas-. Treat."},{"key":"10.1016\/j.biopha.2022.113903_bib15","first-page":"1","article-title":"Optimizing cardiovascular health in patients with cancer: a practical review of risk assessment, monitoring, and prevention of cancer treatment-related cardiovascular toxicity","volume":"40","author":"Dent","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.biopha.2022.113903_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051102","article-title":"Early moderate intensity aerobic exercise intervention prevents doxorubicin-caused cardiac dysfunction through inhibition of cardiac fibrosis and inflammation","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2022.113903_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11030480","article-title":"MicroRNAs, long non-coding RNAs, and circular RNAs in the redox control of cell senescence","volume":"11","author":"Lettieri-Barbato","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2022.113903_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/795602","article-title":"Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress","volume":"2015","author":"Angsutararux","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0006-291X(77)80048-X","article-title":"Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin","volume":"77","author":"Goodman","year":"1977","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.113903_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194968","article-title":"Programmed cell-death by ferroptosis: antioxidants as mitigators","volume":"20","author":"Kajarabille","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib21","article-title":"ROS defense systems and terminal oxidases in bacteria","volume":"10","author":"Borisov","year":"2021","journal-title":"Antioxidantes"},{"key":"10.1016\/j.biopha.2022.113903_bib22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.redox.2017.09.009","article-title":"Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration","volume":"14","author":"Bartesaghi","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040585","article-title":"Matrix metalloproteinases and arterial hypertension: role of oxidative stress and nitric oxide in vascular functional and structural alterations","volume":"11","author":"Prado","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2022.113903_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101523","article-title":"NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy","volume":"34","author":"Zeng","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106013","article-title":"Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics","volume":"136","author":"Mishra","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib27","doi-asserted-by":"crossref","first-page":"3921796","DOI":"10.1155\/2020\/3921796","article-title":"Sinapic ACid Ameliorates Oxidative Stress, Inflammation, and Apoptosis in Acute Doxorubicin-induced Cardiotoxicity via the NF-kappaB-mediated pathway","volume":"2020","author":"Bin","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2022.113903_bib28","doi-asserted-by":"crossref","first-page":"5179468","DOI":"10.1155\/2018\/5179468","article-title":"Inhibition of TRPA1 attenuates doxorubicin-induced acute cardiotoxicity by suppressing oxidative stress, the inflammatory response, and endoplasmic reticulum stress","volume":"2018","author":"Wang","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1039\/D0CS01610A","article-title":"Optical\/electrochemical methods for detecting mitochondrial energy metabolism","volume":"51","author":"Ji","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2022.113903_bib30","doi-asserted-by":"crossref","first-page":"1714841","DOI":"10.1155\/2022\/1714841","article-title":"Nauclea orientalis (L.) bark extract protects rat cardiomyocytes from doxorubicin-induced oxidative stress, inflammation, apoptosis, and DNA fragmentation","volume":"2022","author":"Sandamali","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib31","doi-asserted-by":"crossref","first-page":"H1341","DOI":"10.1152\/ajpheart.00028.2018","article-title":"Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection","volume":"315","author":"Paradies","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2022.113903_bib32","doi-asserted-by":"crossref","first-page":"1125199","DOI":"10.1155\/2021\/1125199","article-title":"Remote inflammatory preconditioning alleviates lipopolysaccharide-induced acute lung injury via inhibition of intrinsic apoptosis in rats","volume":"2021","author":"Liu","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215992","article-title":"CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression","volume":"14","author":"Tscheschner","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113903_bib35","doi-asserted-by":"crossref","first-page":"9850","DOI":"10.1038\/s41598-019-46367-6","article-title":"Blockade of L-type Ca(2+) channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-kappaB pathway","volume":"9","author":"Ikeda","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113903_bib37","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113903_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2022.113903_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.817951","article-title":"Iron promotes cardiac doxorubicin retention and toxicity through downregulation of the mitochondrial exporter ABCB8","volume":"13","author":"Menon","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.12.006","article-title":"The role of autophagy in death of cardiomyocytes","volume":"165","author":"Ikeda","year":"2022","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2022.113903_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3892\/or.2021.7942","article-title":"Beclin1armed oncolytic Vaccinia virus enhances the therapeutic efficacy of RCHOP against lymphoma in vitro and in vivo","volume":"45","author":"Xie","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib42","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.apsb.2020.10.018","article-title":"Natural compounds modulate the autophagy with potential implication of stroke","volume":"11","author":"Ahsan","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113903_bib43","doi-asserted-by":"crossref","first-page":"46663","DOI":"10.18632\/oncotarget.16944","article-title":"Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity","volume":"8","author":"Koleini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113903_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.01.007","article-title":"Autophagic dysregulation in doxorubicin cardiomyopathy","volume":"104","author":"Bartlett","year":"2017","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2022.113903_bib45","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00204-022-03262-w","article-title":"Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation","volume":"96","author":"Sangweni","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113903_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fcimb.2017.00471","article-title":"Bid-induced release of AIF\/EndoG from mitochondria causes apoptosis of macrophages during infection with leptospira interrogans","volume":"7","author":"Hu","year":"2017","journal-title":"Front. Cell Infect. Microbiol"},{"key":"10.1016\/j.biopha.2022.113903_bib48","doi-asserted-by":"crossref","first-page":"44735","DOI":"10.1038\/srep44735","article-title":"Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105182","article-title":"Classical HDACs in the regulation of neuroinflammation","volume":"150","author":"Dai","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2022.113903_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fcvm.2020.00056","article-title":"Review on the role of epigenetic modifications in doxorubicin-induced cardiotoxicity","volume":"7","author":"Kumari","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tox.2017.08.011","article-title":"Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity","volume":"390","author":"Ferreira","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2022.113903_bib52","doi-asserted-by":"crossref","first-page":"15182","DOI":"10.1073\/pnas.1922072117","article-title":"Uncoupling DNA damage from chromatin damage to detoxify doxorubicin","volume":"117","author":"Qiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113903_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000512771","article-title":"Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction","volume":"146","author":"Grakova","year":"2021","journal-title":"Cardiology"},{"key":"10.1016\/j.biopha.2022.113903_bib54","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/bcp.13008","article-title":"Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity","volume":"82","author":"Aminkeng","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib55","article-title":"Safety evaluation of natural drugs in chronic skeletal disorders: a literature review of clinical trials in the past 20 years","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/antiox7100147","article-title":"Cytoprotective effects of natural compounds against oxidative stress","volume":"7","author":"Mehta","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2022.113903_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113165","article-title":"Discovery of natural anti-inflammatory alkaloids: potential leads for the drug discovery for the treatment of inflammation","volume":"213","author":"Bai","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113903_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00145","article-title":"Advances in research on immunoregulation of macrophages by plant polysaccharides","volume":"10","author":"Yin","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2022.113903_bib59","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1039\/C8FO01307A","article-title":"Cardioprotection and natural polyphenols: an update of clinical and experimental studies","volume":"9","author":"Gonzalez","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2022.113903_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03803","article-title":"Modulation of Nrf2 by quercetin in doxorubicin-treated rats","volume":"6","author":"Sharma","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2022.113903_bib61","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ptr.7342","article-title":"Quercetin attenuates the cardiotoxicity of doxorubicin-cyclophosphamide regimen and potentiates its chemotherapeutic effect against triple-negative breast cancer","volume":"36","author":"Zhang","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib62","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2147\/CMAR.S300495","article-title":"Cardioprotective Effect of Quercetin and Sitagliptin in Doxorubicin-Induced Cardiac Toxicity in Rats","volume":"13","author":"Aziz","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib63","article-title":"Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1\/AKT\/Bcl-2 signalling pathway","volume":"8","author":"Zhang","year":"2020","journal-title":"Peerj"},{"key":"10.1016\/j.biopha.2022.113903_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116623","article-title":"Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats","volume":"232","author":"Zare","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.750186","article-title":"Luteolin prevents cardiac dysfunction and improves the chemotherapeutic efficacy of doxorubicin in breast cancer","volume":"8","author":"Shi","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2020.00113","article-title":"Luteolin attenuates doxorubicin-induced cardiotoxicity through promoting mitochondrial autophagy","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2022.113903_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10101506","article-title":"Baicalin enhances chemosensitivity to doxorubicin in breast cancer cells via upregulation of oxidative stress-mediated mitochondria-dependent apoptosis","volume":"10","author":"Lin","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2022.113903_bib68","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.apsb.2019.03.003","article-title":"Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKalpha\/UCP2 pathway","volume":"9","author":"Hu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113903_bib69","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41401-020-0473-8","article-title":"Matrine attenuates pathological cardiac fibrosis via RPS5\/p38 in mice","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2022.113903_bib70","first-page":"5721","article-title":"Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment","volume":"15","author":"Xiong","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2022.113903_bib71","doi-asserted-by":"crossref","first-page":"2150394","DOI":"10.1155\/2019\/2150394","article-title":"Berberine ameliorates doxorubicin-induced cardiotoxicity via a SIRT1\/p66Shc-Mediated pathway","volume":"2019","author":"Wu","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10495-021-01684-y","article-title":"Terpenoids' anti-cancer effects: focus on autophagy","volume":"26","author":"El-Baba","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.biopha.2022.113903_bib73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/0929867327666200121124404","article-title":"Ferroptosis: a novel mechanism of artemisinin and its derivatives in cancer therapy","volume":"28","author":"Zhu","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113903_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10520295.2019.1647457","article-title":"Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats","volume":"95","author":"Aktas","year":"2020","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.biopha.2022.113903_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104313","article-title":"Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects","volume":"146","author":"Li","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib76","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1080\/21655979.2021.1985299","article-title":"Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating nuclear factor - like 2 and Sirtuin 2 signaling pathways","volume":"12","author":"Deng","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2022.113903_bib77","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1021\/acs.jafc.0c05667","article-title":"Nerolidol, a sesquiterpene from the essential oils of aromatic plants, attenuates doxorubicin-induced chronic cardiotoxicity in rats","volume":"69","author":"Meeran","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2022.113903_bib78","doi-asserted-by":"crossref","first-page":"2951697","DOI":"10.1155\/2021\/2951697","article-title":"A systematic review of the potential chemoprotective effects of resveratrol on doxorubicin-induced cardiotoxicity: focus on the antioxidant, antiapoptotic, and anti-inflammatory activities","volume":"2021","author":"Hu","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-020-06941-x","article-title":"The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity","volume":"34","author":"Timm","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib80","article-title":"SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX","author":"Kuno","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.01.018","article-title":"Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B","volume":"79","author":"Tian","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2022.113903_bib82","first-page":"1147","article-title":"Cardioprotective effect of maternal supplementation with resveratrol on toxicity induced by doxorubicin in offspring cardiomyocytes","volume":"117","author":"Brito","year":"2021","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.biopha.2022.113903_bib83","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/1873-3468.14091","article-title":"Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice","volume":"595","author":"Maayah","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2022.113903_bib84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/15376516.2021.1972375","article-title":"Potential protective effect of catechin on doxorubicin-induced cardiotoxicity in adult male albino rats","volume":"32","author":"Saleh","year":"2022","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.biopha.2022.113903_bib85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15376516.2021.1965274","article-title":"Cardioprotective effects of corilagin on doxorubicin induced cardiotoxicity via P13K\/Akt and NF-kappaB signaling pathways in a rat model","volume":"32","author":"Huang","year":"2022","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.biopha.2022.113903_bib86","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jgr.2021.03.001","article-title":"Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects","volume":"45","author":"Wan","year":"2021","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.biopha.2022.113903_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113658","article-title":"Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through the inhibition of autophagy and endoplasmic reticulum stress in mice","volume":"19","author":"Xu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22945","article-title":"Ginsenoside RG1 augments doxorubicin-induced apoptotic cell death in MDA-MB-231 breast cancer cell lines","volume":"36","author":"Liu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172490","article-title":"Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress","volume":"859","author":"Lin","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib90","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s11010-021-04112-6","article-title":"Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling","volume":"476","author":"Luo","year":"2021","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.biopha.2022.113903_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153964","article-title":"Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway","volume":"99","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2022.113903_bib92","article-title":"Therapeutic potentials of poly (ADP-Ribose) polymerase 1 (PARP1) inhibition in multiple sclerosis and animal models: concept revisiting","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib93","article-title":"The expanding universe of PARP1-mediated molecular and therapeutic mechanisms","author":"Huang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2022.113903_bib94","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.apsb.2018.10.008","article-title":"Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation","volume":"9","author":"Lu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113903_bib95","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ptr.7371","article-title":"The potential health benefits of aloin from genus Aloe","volume":"36","author":"Xiao","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib96","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00280-020-04125-w","article-title":"Aloin alleviates doxorubicin-induced cardiotoxicity in rats by abrogating oxidative stress and pro-inflammatory cytokines","volume":"86","author":"Birari","year":"2020","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib97","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/10715762.2020.1822525","article-title":"Coumestrol ameliorates doxorubicin-induced cardiotoxicity via activating AMPKalpha","volume":"54","author":"Wu","year":"2020","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib98","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1039\/C9FO00063A","article-title":"Isodunnianol alleviates doxorubicin-induced myocardial injury by activating protective autophagy","volume":"10","author":"Chen","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2022.113903_bib99","doi-asserted-by":"crossref","first-page":"11989","DOI":"10.1038\/s41598-017-12095-y","article-title":"Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib100","doi-asserted-by":"crossref","first-page":"34082","DOI":"10.18632\/oncotarget.16133","article-title":"Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice","volume":"8","author":"Pillai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113903_bib101","first-page":"186","article-title":"Honokiol antagonizes doxorubicininduced cardiomyocyte senescence by inhibiting TXNIPmediated NLRP3 inflammasome activation","volume":"45","author":"Huang","year":"2020","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.biopha.2022.113903_bib102","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00210-019-01623-4","article-title":"Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats","volume":"392","author":"Aswar","year":"2019","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib103","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/674219","article-title":"Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k\/Akt and p38MAPK pathways","volume":"2014","author":"Cao","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib104","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.18632\/oncotarget.13596","article-title":"Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113903_bib105","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1080\/21655979.2022.2050481","article-title":"Delivery of astragalus polysaccharide by ultrasound microbubbles attenuate doxorubicin-induced cardiomyopathy in rodent animals","volume":"13","author":"Liu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2022.113903_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114177","article-title":"HILIC-MS-based metabolomics reveal that Astragalus polysaccharide alleviates doxorubicin-induced cardiomyopathy by regulating sphingolipid and glycerophospholipid homeostasis","volume":"203","author":"Zhang","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2022.113903_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186483","article-title":"Vitamin D and cardiovascular disease, with emphasis on hypertension, atherosclerosis, and heart failure","volume":"21","author":"Latic","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib108","article-title":"Cytoprotective effect of vitamin D on doxorubicin-induced cardiac toxicity in triple negative breast cancer","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030477","article-title":"The role of nicotinamide in cancer chemoprevention and therapy","volume":"10","author":"Nikas","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2022.113903_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111679","article-title":"Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: emphasis on calcium homeostasis","volume":"140","author":"Awad","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib111","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1111\/jcmm.13231","article-title":"Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase","volume":"21","author":"Octavia","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib112","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/13880209.2017.1299768","article-title":"Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model","volume":"55","author":"Ahmad","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.746","article-title":"Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2-mediated chromatin remodelling","volume":"12","author":"Xie","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib114","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13390","article-title":"The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: a narrative review","volume":"23","author":"Pivonello","year":"2022","journal-title":"Obes. Rev."},{"key":"10.1016\/j.biopha.2022.113903_bib115","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/OTT.S298512","article-title":"Role and therapeutic potential of melatonin in various type of cancers","volume":"14","author":"Gurunathan","year":"2021","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib116","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s12276-021-00675-y","article-title":"Melatonin and doxorubicin synergistically enhance apoptosis via autophagy-dependent reduction of AMPKalpha1 transcription in human breast cancer cells","volume":"53","author":"Tran","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117173","article-title":"The role of melatonin on doxorubicin-induced cardiotoxicity: a systematic review","volume":"241","author":"Najafi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib118","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1111\/jcmm.15057","article-title":"Melatonin attenuates doxorubicin-induced cardiotoxicity through preservation of YAP expression","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib119","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2021.12.019","article-title":"Context-dependent transcriptional regulations of YAP\/TAZ in cancer","volume":"527","author":"Guo","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.113903_bib120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","article-title":"YAP\/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis","volume":"24","author":"Li","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115902","article-title":"Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression","volume":"437","author":"Sun","year":"2022","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib122","doi-asserted-by":"crossref","first-page":"3563518","DOI":"10.1155\/2022\/3563518","article-title":"Antioxidant effects of irisin in liver diseases: mechanistic insights","volume":"2022","author":"Zhao","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102120","article-title":"Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells","volume":"46","author":"Pan","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib124","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.12659\/MSM.917625","article-title":"Irisin enhances doxorubicin-induced cell apoptosis in pancreatic cancer by inhibiting the PI3K\/AKT\/NF-kappaB pathway","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2022.113903_bib125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","article-title":"FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2022.113903_bib126","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2022.113903_bib127","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028472","article-title":"Cytokines in Cancer Immunotherapy","volume":"10","author":"Waldmann","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jir.2018.0019","article-title":"Cytokines in the treatment of cancer","volume":"39","author":"Conlon","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2022.113903_bib129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2022.113903_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040890","article-title":"Interleukin-10 mitigates doxorubicin-induced endoplasmic reticulum stress as well as cardiomyopathy","volume":"10","author":"Malik","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2022.113903_bib131","article-title":"The mRNA expression of Il6 and Pdcd1 are predictive and protective factors for doxorubicininduced cardiotoxicity","volume":"23","author":"Kanno","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib132","doi-asserted-by":"crossref","first-page":"6611085","DOI":"10.1155\/2021\/6611085","article-title":"Anti-Interleukin-16-neutralizing antibody attenuates cardiac inflammation and protects against cardiac injury in doxorubicin-treated mice","volume":"2021","author":"Zhang","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2022.113903_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117844","article-title":"Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice","volume":"255","author":"Ye","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib134","doi-asserted-by":"crossref","first-page":"87415","DOI":"10.18632\/oncotarget.20558","article-title":"Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR\/Nrf-2\/HO-1 pathway","volume":"8","author":"Koleini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113903_bib135","doi-asserted-by":"crossref","first-page":"H279","DOI":"10.1152\/ajpheart.00587.2018","article-title":"Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity","volume":"316","author":"Koleini","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2022.113903_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.410","article-title":"Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1\/LKB1\/AMPK pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113903_bib137","article-title":"Transient exposure of endothelial cells to doxorubicin leads to long-lasting vascular endothelial growth factor receptor 2 downregulation","volume":"11","author":"Graziani","year":"2022","journal-title":"Cells-Basel"},{"key":"10.1016\/j.biopha.2022.113903_bib138","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.2147\/IJN.S245170","article-title":"Nano-encapsulation of coenzyme Q10 in secondary and tertiary nano-emulsions for enhanced cardioprotection and hepatoprotection in human cardiomyocytes and hepatocytes during exposure to anthracyclines and trastuzumab","volume":"15","author":"Quagliariello","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2022.113903_bib139","first-page":"158","article-title":"Efficacy of coenzyme Q10 in supportive therapy of the cardiovascular diseases and in the prevention of cardiotoxicity caused by chemotherapy","volume":"49","author":"Miedziaszczyk","year":"2021","journal-title":"Pol. Merkur Lek."},{"key":"10.1016\/j.biopha.2022.113903_bib140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s12012-021-09685-8","article-title":"The protective effects of coenzyme Q10 and lisinopril against doxorubicin-induced cardiotoxicity in rats: a stereological and electrocardiogram study","volume":"21","author":"Rahmanifard","year":"2021","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib141","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12012-019-09547-4","article-title":"Coenzyme Q10 cardioprotective effects against doxorubicin-induced cardiotoxicity in wistar rat","volume":"20","author":"Botelho","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib142","article-title":"SGK1 in human cancer: emerging roles and mechanisms","volume":"10","author":"Sang","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2022.113903_bib143","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1080\/21655979.2021.2013109","article-title":"Upregulation of serum and glucocorticoid-regulated kinase 1 (SGK1) ameliorates doxorubicin-induced cardiotoxic injury, apoptosis, inflammation and oxidative stress by suppressing glucose regulated protein 78 (GRP78)-mediated endoplasmic reticulum stress","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2022.113903_bib144","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1002\/jcp.26529","article-title":"RRM2 promotes the progression of human glioblastoma","volume":"233","author":"Li","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.113903_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020299","article-title":"RRM2 alleviates doxorubicin-induced cardiotoxicity through the AKT\/mTOR signaling pathway","volume":"12","author":"Jiao","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2022.113903_bib146","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1096\/fj.201901291RRRRR","article-title":"8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2\/3 and interacting with Smad7","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2022.113903_bib147","doi-asserted-by":"crossref","first-page":"9180267","DOI":"10.1155\/2022\/9180267","article-title":"8-Oxoguanine DNA glycosylase (OGG1) deficiency exacerbates doxorubicin-induced cardiac dysfunction","volume":"2022","author":"Anene-Nzelu","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib148","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2022.113903_bib149","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1111\/jcmm.14562","article-title":"Role of cardiac progenitor cell-derived exosome-mediated microRNA-210 in cardiovascular disease","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2022.113903_bib150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s13287-020-01881-7","article-title":"HIF-1alpha overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.03.016","article-title":"Cardioprotective microRNAs: lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease","volume":"285","author":"Moghaddam","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2022.113903_bib152","doi-asserted-by":"crossref","first-page":"H460","DOI":"10.1152\/ajpheart.00056.2019","article-title":"Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis","volume":"317","author":"Tavakoli","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2022.113903_bib153","article-title":"Exosome treatment enhances anti-inflammatory m2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy","volume":"8","author":"Singla","year":"2019","journal-title":"Cells-Basel"},{"key":"10.1016\/j.biopha.2022.113903_bib154","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020589","article-title":"Exosomal micro-RNA-96 derived from bone marrow mesenchymal stem cells inhibits doxorubicin-induced myocardial toxicity by inhibiting the Rac1\/Nuclear Factor-kappaB signaling pathway","volume":"10","author":"Lei","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2022.113903_bib155","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/jcmm.17230","article-title":"MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT","volume":"26","author":"Meng","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib156","doi-asserted-by":"crossref","first-page":"5184135","DOI":"10.1155\/2022\/5184135","article-title":"miR-488-3p protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting cyclinG1","volume":"2022","author":"Yan","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib157","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/CIRCRESAHA.119.316061","article-title":"The tumor-suppressive human circular RNA CircITCH sponges miR-330-5p to ameliorate doxorubicin-induced cardiotoxicity through upregulating SIRT6, Survivin, and SERCA2a","volume":"127","author":"Han","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170773","article-title":"Osteocrin alleviates cardiac hypertrophy via attenuating oxidative stress","volume":"152","author":"Ji","year":"2022","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2022.113903_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.124","article-title":"Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity","volume":"10","author":"Hu","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092092","article-title":"The emerging role of l-Glutamine in cardiovascular health and disease","volume":"11","author":"Durante","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2022.113903_bib161","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0148607115581838","article-title":"Nutrition modulation of cardiotoxicity and anticancer efficacy related to doxorubicin chemotherapy by glutamine and omega-3 polyunsaturated fatty acids","volume":"40","author":"Xue","year":"2016","journal-title":"JPEN J. Parent. Enter. Nutr."},{"key":"10.1016\/j.biopha.2022.113903_bib162","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.2174\/1871520621666201229115612","article-title":"The synthesis of nano-doxorubicin and its anticancer effect","volume":"21","author":"Zhu","year":"2021","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.biopha.2022.113903_bib163","first-page":"970","article-title":"Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance","volume":"116","author":"Gyongyosi","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2022.113903_bib164","doi-asserted-by":"crossref","first-page":"18481","DOI":"10.1038\/s41598-020-75614-4","article-title":"Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin","volume":"10","author":"Szmit","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib165","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00066-021-01835-9","article-title":"Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer","volume":"197","author":"Chen","year":"2021","journal-title":"Strahl. Onkol."},{"key":"10.1016\/j.biopha.2022.113903_bib166","first-page":"385","article-title":"Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than Doxil","volume":"15","author":"Zhang","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib167","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.actbio.2021.12.019","article-title":"Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy","volume":"140","author":"Pereira","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2022.113903_bib168","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2174\/1568026621666210412151700","article-title":"A review on natural sources derived protein nanoparticles as anticancer agents","volume":"21","author":"Bhattacharya","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113903_bib169","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1725","article-title":"Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2022.113903_bib170","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2217\/nnm-2021-0329","article-title":"Doxorubicin nanomedicine based on ginsenoside Rg1 with alleviated cardiotoxicity and enhanced antitumor activity","volume":"16","author":"Li","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2022.113903_bib171","doi-asserted-by":"crossref","first-page":"10050","DOI":"10.1039\/D0TB01869D","article-title":"Chemical and physical chitosan hydrogels as prospective carriers for drug delivery: a review","volume":"8","author":"Tian","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2022.113903_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/nano12030502","article-title":"Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid","volume":"12","author":"Siva","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2022.113903_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111279","article-title":"Catechol-modified chitosan\/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells","volume":"196","author":"Pornpitchanarong","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2022.113903_bib174","article-title":"Light-responsive micelles loaded with doxorubicin for osteosarcoma suppression","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib175","article-title":"Multifunctional MnO2 nanoparticles for tumor microenvironment modulation and cancer therapy","volume":"13","author":"Yang","year":"2021","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2022.113903_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.781982","article-title":"PEGylated doxorubicin prodrug-forming reduction-sensitive micelles with high drug loading and improved anticancer therapy","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2022.113903_bib177","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1080\/10717544.2021.2008052","article-title":"Targeted delivery by pH-responsive mPEG-S-PBLG micelles significantly enhances the anti-tumor efficacy of doxorubicin with reduced cardiotoxicity","volume":"28","author":"Feng","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2022.113903_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121303","article-title":"Dendrimers in vaccine delivery: Recent progress and advances","volume":"280","author":"Chowdhury","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2022.113903_bib179","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1080\/09205063.2021.1938859","article-title":"Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics","volume":"32","author":"Singh","year":"2021","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.biopha.2022.113903_bib180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181944","article-title":"Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model","volume":"12","author":"Kuruvilla","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113903_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202000392","article-title":"PMPC modified PAMAM dendrimer enhances brain tumor-targeted drug delivery","volume":"21","author":"Ban","year":"2021","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biopha.2022.113903_bib182","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.biopha.2022.113903_bib183","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jgr.2021.03.001","article-title":"Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects","volume":"45","author":"Wan","year":"2021","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.biopha.2022.113903_bib184","first-page":"3229","article-title":"Effect of fermented Cordyceps sinensis on doxorubicininduced cardiotoxicity in rats","volume":"18","author":"Wu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153597","article-title":"Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity","volume":"88","author":"Wu","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2022.113903_bib186","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jpba.2018.02.012","article-title":"Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: Insight by LC-MS based non-targeted metabolomic analysis","volume":"152","author":"Yi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2022.113903_bib187","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/13880209.2022.2046801","article-title":"In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity","volume":"60","author":"Zhou","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2022.113903_bib188","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11858","article-title":"Shengxian decoction decreases doxorubicininduced cardiac apoptosis by regulating the TREM1\/NFkappaB signaling pathway","volume":"23","author":"Yao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib189","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jat.3943","article-title":"Aconitine induces cardiotoxicity through regulation of calcium signaling pathway in zebrafish embryos and in H9c2 cells","volume":"40","author":"Li","year":"2020","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153468","article-title":"Ginsenoside Rb1 ameliorates cardiotoxicity triggered by aconitine via inhibiting calcium overload and pyroptosis","volume":"83","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2022.113903_bib191","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/1440-1681.13036","article-title":"Update on pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity","volume":"46","author":"Corremans","year":"2019","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.biopha.2022.113903_bib192","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cmdc.202000131","article-title":"Antitumour anthracyclines: progress and perspectives","volume":"15","author":"Martins-Teixeira","year":"2020","journal-title":"Chemmedchem"},{"key":"10.1016\/j.biopha.2022.113903_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.04.009","article-title":"Structural modifications in the sugar moiety as a key to improving the anticancer effectiveness of doxorubicin","volume":"178","author":"Denel-Bobrowska","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib194","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.113903_bib195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2022.113903_bib196","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020151","article-title":"Beyond Lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer","volume":"15","author":"Morofuji","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2022.113903_bib197","first-page":"302","article-title":"Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function","volume":"31","author":"Chotenimitkhun","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2022.113903_bib198","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.yjmcc.2019.12.007","article-title":"Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition","volume":"138","author":"Oh","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2022.113903_bib199","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1074248418821721","article-title":"Effect of rosuvastatin in preventing chemotherapy-induced cardiotoxicity in women with breast cancer: a randomized, single-blind, placebo-controlled trial","volume":"24","author":"Nabati","year":"2019","journal-title":"J. Cardiovasc Pharm. Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4274\/tjps.galenos.2021.70745","article-title":"Ameliorative potential of rosuvastatin on doxorubicin-induced cardiotoxicity by modulating oxidative damage in rats","volume":"19","author":"Rajangam","year":"2022","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib201","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","volume":"1","author":"Zhu","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2022.113903_bib202","author":"Bansal","year":"2022","journal-title":"Felodipine"},{"key":"10.1016\/j.biopha.2022.113903_bib203","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.3892\/mmr.2017.7181","article-title":"Felodipine inhibits ox-LDL-induced reactive oxygen species production and inflammation in human umbilical vein endothelial cells","volume":"16","author":"Qi","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib204","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.etap.2013.07.007","article-title":"Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices","volume":"36","author":"Gandhi","year":"2013","journal-title":"Environ. Toxicol. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10641963.2019.1676770","article-title":"Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity","volume":"42","author":"Hassan","year":"2020","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.biopha.2022.113903_bib206","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12935-019-0912-0","article-title":"Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals","volume":"19","author":"Al-Malky","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.biopha.2022.113903_bib207","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10557-019-06917-6","article-title":"The effect of ranolazine on glycemic control: a narrative review to define the target population","volume":"33","author":"Lisi","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib208","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1111\/bph.13791","article-title":"Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction","volume":"174","author":"Cappetta","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib209","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ejhf.50","article-title":"Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction","volume":"16","author":"Tocchetti","year":"2014","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2022.113903_bib210","first-page":"304","article-title":"Protective Effects Of Trimetazidine Against Doxorubicin-Induced Cardiotoxicity And Hepatotoxicity In Mice","volume":"32","author":"Sikandar","year":"2020","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"10.1016\/j.biopha.2022.113903_bib211","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/tox.23120","article-title":"Trimetazidine improved adriamycin-induced cardiomyopathy by downregulating TNF-alpha, BAX, and VEGF immunoexpression via an antioxidant mechanism","volume":"36","author":"Eid","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CNQ.0000000000000401","article-title":"SGLT-2 Inhibitor Use in Heart Failure: A Review for Nurses","volume":"45","author":"March","year":"2022","journal-title":"Crit. Care Nurs. Q"},{"key":"10.1016\/j.biopha.2022.113903_bib213","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00204-020-02951-8","article-title":"Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"95","author":"Chang","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib214","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2022.113903_bib215","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.121.057812","article-title":"Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial","volume":"145","author":"Butler","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.113903_bib216","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2147\/TCRM.S188761","article-title":"Use of levosimendan in acute and advanced heart failure: short review on available real-world data","volume":"15","author":"Pashkovetsky","year":"2019","journal-title":"Ther. Clin. Risk Manag"},{"key":"10.1016\/j.biopha.2022.113903_bib217","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233176","article-title":"Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels","volume":"15","author":"Rieg","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113903_bib218","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/cvr\/cvz163","article-title":"Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy","volume":"116","author":"Efentakis","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib219","doi-asserted-by":"crossref","first-page":"8593617","DOI":"10.1155\/2020\/8593617","article-title":"Levosimendan protects against doxorubicin-induced cardiotoxicity by regulating the PTEN\/Akt pathway","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2022.113903_bib220","article-title":"Carvedilol prevents pancreatic beta-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory","volume":"138","author":"Amirshahrokhi","year":"2021","journal-title":"Cytokines, NF-kappaB, COX-2, iNOS Oxid. Stress, Cytokine"},{"key":"10.1016\/j.biopha.2022.113903_bib221","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jjcc.2019.07.011","article-title":"Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure","volume":"75","author":"Toyoda","year":"2020","journal-title":"J. Cardiol."},{"key":"10.1016\/j.biopha.2022.113903_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121276","article-title":"Matrix metalloproteinase-2 inhibition in acute ischemia-reperfusion heart injury-cardioprotective properties of carvedilol","volume":"14","author":"Skrzypiec-Spring","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2022.113903_bib223","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/FJC.0000000000000470","article-title":"Cardioprotective effects of carvedilol in inhibiting doxorubicin-induced cardiotoxicity","volume":"69","author":"Nabati","year":"2017","journal-title":"J. Cardiovasc. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib224","first-page":"928","article-title":"Doxorubicin-induced and trastuzumab-induced cardiotoxicity in mice is not prevented by metoprolol, ESC","volume":"8","author":"Nicol","year":"2021","journal-title":"Heart Fail"},{"key":"10.1016\/j.biopha.2022.113903_bib225","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s43440-019-00034-9","article-title":"Bisoprolol and linagliptin ameliorated electrical and mechanical isometric myocardial contractions in doxorubicin-induced cardiomyopathy in rats","volume":"72","author":"Aykan","year":"2020","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.biopha.2022.113903_bib226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12012-019-09558-1","article-title":"Cardioprotective effects and duration of beta blocker therapy in anthracycline-treated patients: a systematic review and meta-analysis","volume":"20","author":"Xu","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib227","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12012-016-9365-z","article-title":"Effect of enalapril on preventing anthracycline-induced cardiomyopathy","volume":"17","author":"Janbabai","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib228","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cvr\/cvx162","article-title":"Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity","volume":"114","author":"Hullin","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib229","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3892\/etm.2021.10516","article-title":"Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K\/Akt pathway","volume":"22","author":"Zhan","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2022.113903_bib230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12272-017-0980-4","article-title":"Valsartan regulates TGF-beta\/Smads and TGF-beta\/p38 pathways through lncRNA CHRF to improve doxorubicin-induced heart failure","volume":"41","author":"Chen","year":"2018","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib231","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaccao.2020.09.007","article-title":"Dual angiotensin receptor-neprilysin inhibition with sacubitril\/valsartan attenuates systolic dysfunction in experimental doxorubicin-induced cardiotoxicity","volume":"2","author":"Boutagy","year":"2020","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.biopha.2022.113903_bib232","doi-asserted-by":"crossref","first-page":"821","DOI":"10.5152\/AnatolJCardiol.2021.356","article-title":"Angiotensin receptor-neprilysin inhibition by sacubitril\/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway","volume":"25","author":"Dindas","year":"2021","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.biopha.2022.113903_bib233","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00204-022-03241-1","article-title":"Sacubitril\/valsartan reduces endoplasmic reticulum stress in a rat model of doxorubicin-induced cardiotoxicity","volume":"96","author":"Kim","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2022.113903_bib234","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1755-5922.12189","article-title":"Spironolactone attenuates doxorubicin-induced cardiotoxicity in rats","volume":"34","author":"Liu","year":"2016","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ejhf.196","article-title":"Protective effects of spironolactone against anthracycline-induced cardiomyopathy","volume":"17","author":"Akpek","year":"2015","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2022.113903_bib236","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2019.12.027","article-title":"Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes","volume":"523","author":"Yu","year":"2020","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.113903_bib237","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.418","article-title":"Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers","volume":"8","author":"Henninger","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113903_bib238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2017.09.012","article-title":"Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite","volume":"392","author":"Bures","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2022.113903_bib239","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1158\/1078-0432.CCR-21-1376","article-title":"Doxorubicin-Dexrazoxane from day 1 for soft-tissue sarcomas: the road to cardioprotection","volume":"27","author":"Benjamin","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.113903_bib240","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/1078-0432.CCR-20-4592","article-title":"Prospective evaluation of doxorubicin cardiotoxicity in patients with advanced soft-tissue sarcoma treated in the ANNOUNCE phase III randomized trial","volume":"27","author":"Jones","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.113903_bib241","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001025","article-title":"Dexrazoxane preferentially mitigates doxorubicin cardiotoxicity in female children with sarcoma","volume":"6","author":"Narayan","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.biopha.2022.113903_bib242","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2013.201","article-title":"Topoisomerase 2beta: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity","volume":"95","author":"Vejpongsa","year":"2014","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2022.113903_bib243","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/CAD.0000000000000514","article-title":"Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival","volume":"28","author":"Tahover","year":"2017","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2022.113903_bib244","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.871","article-title":"Donepezil improves vascular function in a mouse model of Alzheimer's disease","volume":"9","author":"Pellegrini","year":"2021","journal-title":"Pharm. Res. Perspect."},{"key":"10.1016\/j.biopha.2022.113903_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105882","article-title":"Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis","volume":"173","author":"Khuanjing","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113903_bib246","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2018.1458090","article-title":"Discovery and development of varenicline for smoking cessation","volume":"13","author":"Jordan","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.biopha.2022.113903_bib247","first-page":"11350","article-title":"Varenicline enhances the survival of doxorubicin-treated mice","volume":"24","author":"Alhowail","year":"2020","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib248","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/434195","article-title":"Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats","volume":"2012","author":"Ashour","year":"2012","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2022.113903_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117498","article-title":"Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via the MAPK and AMPK pathways","volume":"249","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113903_bib250","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1021\/acs.molpharmaceut.9b00199","article-title":"Co-Delivery of metformin enhances the antimultidrug resistant tumor effect of doxorubicin by improving hypoxic tumor microenvironment","volume":"16","author":"Li","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib251","article-title":"Doxycycline attenuates doxorubicin-induced cardiotoxicity by improving myocardial energy metabolism in rats","volume":"9","author":"Dantas","year":"2022","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.biopha.2022.113903_bib252","article-title":"Dimethyl fumarate ameliorates doxorubicin-induced cardiotoxicity by activating the Nrf2 pathway","volume":"13","author":"Hu","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2022.113903_bib253","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.802502","article-title":"Neuraminidase1 inhibitor protects against doxorubicin-induced cardiotoxicity via suppressing Drp1-Dependent mitophagy","volume":"9","author":"Qin","year":"2021","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:20:52Z","timestamp":1778242852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222012926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":253,"alternative-id":["S0753332222012926"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113903","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113903"}}